These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32820405)

  • 1. Visualization of Chromatin Dynamics by Live Cell Microscopy Using CRISPR/Cas9 Gene Editing and ANCHOR Labeling.
    Fok ET; Fanucchi S; Bystricky K; Mhlanga MM
    Methods Mol Biol; 2021; 2157():197-212. PubMed ID: 32820405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
    Daer RM; Cutts JP; Brafman DA; Haynes KA
    ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies.
    Verkuijl SA; Rots MG
    Curr Opin Biotechnol; 2019 Feb; 55():68-73. PubMed ID: 30189348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing.
    Liu B; Chen S; Rose A; Chen D; Cao F; Zwinderman M; Kiemel D; Aïssi M; Dekker FJ; Haisma HJ
    Nucleic Acids Res; 2020 Jan; 48(2):517-532. PubMed ID: 31799598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing During Development Using the CRISPR-Cas Technology.
    Arzate-Mejía RG; Licona-Limón P; Recillas-Targa F
    Methods Mol Biol; 2018; 1752():177-190. PubMed ID: 29564772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Mediated Programmable 3D Genome Positioning and Nuclear Organization.
    Wang H; Xu X; Nguyen CM; Liu Y; Gao Y; Lin X; Daley T; Kipniss NH; La Russa M; Qi LS
    Cell; 2018 Nov; 175(5):1405-1417.e14. PubMed ID: 30318144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing Live Chromatin Dynamics through CRISPR-Based Imaging Techniques.
    Chaudhary N; Im JK; Nho SH; Kim H
    Mol Cells; 2021 Sep; 44(9):627-636. PubMed ID: 34588320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 genome editing throws descriptive 3-D genome folding studies for a loop.
    Beagan JA; Phillips-Cremins JE
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):286-99. PubMed ID: 27265842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-mediated genome editing assists protein dynamics studies in live cells.
    Carrasco-Padilla C; Roda-Navarro P
    Eur J Cell Biol; 2022 Apr; 101(2):151203. PubMed ID: 35101771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing 3D genome by CRISPR/Cas9.
    Liu PF; Wu Q
    Yi Chuan; 2020 Jan; 42(1):18-31. PubMed ID: 31956094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing the Nucleome Using the CRISPR-Cas9 System: From in vitro to in vivo.
    Maloshenok LG; Abushinova GA; Ryazanova AY; Bruskin SA; Zherdeva VV
    Biochemistry (Mosc); 2023 Jan; 88(Suppl 1):S123-S149. PubMed ID: 37069118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.
    Shao M; Xu TR; Chen CS
    Dongwuxue Yanjiu; 2016 Jul; 37(4):191-204. PubMed ID: 27469250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosome breathing and remodeling constrain CRISPR-Cas9 function.
    Isaac RS; Jiang F; Doudna JA; Lim WA; Narlikar GJ; Almeida R
    Elife; 2016 Apr; 5():. PubMed ID: 27130520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new normal of structure/function studies in the era of CRISPR/Cas9.
    Logsdon GA; Black BE
    Biochem J; 2018 May; 475(9):1635-1642. PubMed ID: 29764955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An RNA-aptamer-based two-color CRISPR labeling system.
    Wang S; Su JH; Zhang F; Zhuang X
    Sci Rep; 2016 May; 6():26857. PubMed ID: 27229896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.